PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: Restricted expression of type I interferon receptor by CCR5-expressing leukocytes

Clinical Immunology

Volumn 129, Issue 1, 2008, Pages 132-144

  Boasso, Adriano ^a   Hardy, Andrew W ^a   Landay, Alan L ^b   Martinson, Jeffrey L ^b   Anderson, Stephanie A ^c   Dolan, Matthew J ^c   Clerici, Mario ^d,e   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Antigen presenting cells; CCR5; HIV 1; IFN ; Monocytes; PDL 1; Plasmacytoid dendritic cells; Proliferation; T lymphocytes

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 2; B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERFERON; PROGRAMMED DEATH 1; PROGRAMMED DEATH LIGAND 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENDOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; HIV-1; HUMANS; INTERFERON TYPE I; MONOCYTES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, CCR5; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; UP-REGULATION; VIRAL LOAD;

EID: 51249105975     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.05.009     Document Type: Article

References (59)

1. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
2. Lespagnard L., Mettens P., Urbain J., and Moser M. Role of B7 costimulation in the induction of T and B cell responses by dendritic cells in vivo. Adv. Exp. Med. Biol. 417 (1997) 529-533
3. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
4. Dolan M.J., Clerici M., Blatt S.P., Hendrix C.W., Melcher G.P., Boswell R.N., Freeman T.M., Ward W., Hensley R., and Shearer G.M. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 172 (1995) 79-87
5. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 (2007) 239-245
6. Tsushima F., Yao S., Shin T., Flies A., Flies S., Xu H., Tamada K., Pardoll D.M., and Chen L. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood (2007)
7. Liu J., Hamrouni A., Wolowiec D., Coiteux V., Kuliczkowski K., Hetuin D., Saudemont A., and Quesnel B. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression following stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood (2007)
8. Schoop R., Wahl P., Le Hir M., Heemann U., Wang M., and Wuthrich R.P. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol. Dial. Transplant. 19 (2004) 2713-2720
9. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., and Carreno B.M. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32 (2002) 634-643
10. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., and Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97 (2001) 1809-1816
11. Blank C., and Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol. Immunother. 56 (2007) 739-745
12. Yao S., and Chen L. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade. Trends Mol. Med. 12 (2006) 244-246
13. Geng L., Jiang G., Fang Y., Dong S., Xie H., Chen Y., Shen M., and Zheng S. B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J. Viral Hepat. 13 (2006) 725-733
14. Maier H., Isogawa M., Freeman G.J., and Chisari F.V. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J. Immunol. 178 (2007) 2714-2720
15. Hofmann B., Nishanian P., Baldwin R.L., Insixiengmay P., Nel A., and Fahey J.L. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J. Immunol. 145 (1990) 3699-3705
16. Janossy G., Borthwick N., Lomnitzer R., Medina E., Squire S.B., Phillips A.N., Lipman M., Johnson M.A., Lee C., and Bofill M. Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages. Aids 7 (1993) 613-624
17. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., and Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
18. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., Boulassel M.R., Delwart E., Sepulveda H., Balderas R.S., Routy J.P., Haddad E.K., and Sekaly R.P. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12 (2006) 1198-1202
19. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., Precopio M.L., Schacker T., Roederer M., Douek D.C., and Koup R.A. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 203 (2006) 2281-2292
20. Chen L., Zhang Z., Chen W., Zhang Z., Li Y., Shi M., Zhang J., Chen L., Wang S., and Wang F.S. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J. Immunol. 178 (2007) 6634-6641
21. Cecchinato V., Tryniszewska E., Ma Z.M., Vaccari M., Boasso A., Tsai W.P., Petrovas C., Fuchs D., Heraud J.M., Venzon D., Shearer G.M., Koup R.A., Lowy I., Miller C.J., and Franchini G. Immune activation driven by ctla-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J. Immunol. 180 (2008) 5439-5447
22. Trabattoni D., Saresella M., Biasin M., Boasso A., Piacentini L., Ferrante P., Dong H., Maserati R., Shearer G.M., Chen L., and Clerici M. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101 (2003) 2514-2520
23. Rosignoli G., Cranage A., Burton C., Nelson M., Steel A., Gazzard B., Gotch F., and Imami N. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. Aids 21 (2007) 1379-1381
24. Clerici M., Galli M., Bosis S., Gervasoni C., Moroni M., and Norbiato G. Immunoendocrinologic abnormalities in human immunodeficiency virus infection. Ann. N. Y. Acad. Sci. 917 (2000) 956-961
25. Lieberman J., Shankar P., Manjunath N., and Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98 (2001) 1667-1677
26. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess Jr. J.W., Vasquez G.M., Wiltrout T.A., Chertova E., Grimes M.K., Sattentau Q., Arthur L.O., Henderson L.E., and Lifson J.D. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72 (1998) 7992-8001
27. Herbeuval J.P., Hardy A.W., Boasso A., Anderson S.A., Dolan M.J., Dy M., and Shearer G.M. Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13974-13979
28. Montoya C.J., Jie H.B., Al-Harthi L., Mulder C., Patino P.J., Rugeles M.T., Krieg A.M., Landay A.L., and Wilson S.B. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J. Immunol. 177 (2006) 1028-1039
29. Gorden K.B., Gorski K.S., Gibson S.J., Kedl R.M., Kieper W.C., Qiu X., Tomai M.A., Alkan S.S., and Vasilakos J.P. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174 (2005) 1259-1268
30. Boasso A., Herbeuval J.P., Hardy A.W., Anderson S.A., Dolan M.J., Fuchs D., and Shearer G.M. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109 (2007) 3351-3359
31. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
32. Muhlbauer M., Fleck M., Schutz C., Weiss T., Froh M., Blank C., Scholmerich J., and Hellerbrand C. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J. Hepatol. 45 (2006) 520-528
33. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., and Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115 (2005) 3265-3275
34. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., and Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33 (2003) 1633-1641
35. McCluskie M.J., and Krieg A.M. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. Curr. Top. Microbiol. Immunol. 311 (2006) 155-178
36. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., and Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166 (2001) 2372-2377
37. Abe M., Wang Z., de Creus A., and Thomson A.W. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5 (2005) 1808-1819
38. Herbeuval J.P., Nilsson J., Boasso A., Hardy A.W., Kruhlak M.J., Anderson S.A., Dolan M.J., Dy M., Andersson J., and Shearer G.M. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7000-7005
39. von Sydow M., Sonnerborg A., Gaines H., and Strannegard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retroviruses 7 (1991) 375-380
40. Herbeuval J.P., Grivel J.C., Boasso A., Hardy A.W., Chougnet C., Dolan M.J., Yagita H., Lifson J.D., and Shearer G.M. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106 (2005) 3524-3531
41. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
42. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., and Dandekar S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77 (2003) 11708-11717
43. Estes J.D., Li Q., Reynolds M.R., Wietgrefe S., Duan L., Schacker T., Picker L.J., Watkins D.I., Lifson J.D., Reilly C., Carlis J., and Haase A.T. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193 (2006) 703-712
44. Veazey R.S., DeMaria M., Chalifoux L.V., Shvetz D.E., Pauley D.R., Knight H.L., Rosenzweig M., Johnson R.P., Desrosiers R.C., and Lackner A.A. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 (1998) 427-431
45. Little S.J., McLean A.R., Spina C.A., Richman D.D., and Havlir D.V. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190 (1999) 841-850
46. Borrow P., Lewicki H., Hahn B.H., Shaw G.M., and Oldstone M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68 (1994) 6103-6110
47. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., and Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68 (1994) 4650-4655
48. Herbeuval J.P., and Shearer G.M. HIV-1 immunopathogenesis: how good interferon turns bad. Clin. Immunol. 123 (2007) 121-128
49. Vilcek J. Boosting p53 with interferon and viruses. Nat. Immunol. 4 (2003) 825-826
50. Pandrea I., Apetrei C., Gordon S., Barbercheck J., Dufour J., Bohm R., Sumpter B., Roques P., Marx P.A., Hirsch V.M., Kaur A., Lackner A.A., Veazey R.S., and Silvestri G. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 109 (2007) 1069-1076
51. Martinson J.A., Tenorio A.R., Montoya C.J., Al-Harthi L., Gichinga C.N., Krieg A.M., Baum L.L., and Landay A.L. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology 120 (2007) 526-535
52. Haffar O.K., Smithgall M.D., Bradshaw J., Brady B., Damle N.K., and Linsley P.S. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11094-11098
53. Kochli C., Wendland T., Frutig K., Grunow R., Merlin S., and Pichler W.J. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65 (1999) 197-201
54. Wolthers K.C., Otto S.A., Lens S.M., Kolbach D.N., van Lier R.A., Miedema F., and Meyaard L. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells. Eur. J. Immunol. 26 (1996) 1700-1706
55. Wyss-Coray T., Mauri-Hellweg D., Baumann K., Bettens F., Grunow R., and Pichler W.J. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23 (1993) 2175-2180
56. Andersson J., Boasso A., Nilsson J., Zhang R., Shire N.J., Lindback S., Shearer G.M., and Chougnet C.A. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174 (2005) 3143-3147
57. Sansom D.M., Manzotti C.N., and Zheng Y. What's the difference between CD80 and CD86?. Trends Immunol. 24 (2003) 314-319
58. Butte M.J., Keir M.E., Phamduy T.B., Sharpe A.H., and Freeman G.J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27 (2007) 111-122
59. Clerici M., Landay A.L., Kessler H.A., Zajac R.A., Boswell R.N., Muluk S.C., and Shearer G.M. Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J. Immunol. 146 (1991) 2207-2213